Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 6/20 | 0.61 |
| ▸ | ACE | P12821 | 3/20 | 0.56 |
| ▸ | CPA1 | P15085 | 3/20 | 0.56 |
| ▸ | ACE2 | Q9BYF1 | 3/20 | 0.56 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.55 |
| ▸ | ALPI | P09923 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.53 |
| ▸ | XIAP | P98170 | 1/20 | 0.53 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29525004 | 1.00 | MME (0.61) | MMEACECPA1ACE2NAALAD2 | |
| SCHEMBL10618864 | 1.00 | MME (0.61) | MMEACECPA1ACE2NAALAD2 | |
| SCHEMBL30494635 | 1.00 | MME (0.61) | MMEACECPA1ACE2NAALAD2 | |
| SCHEMBL135367 | 1.00 | MME (0.61) | MMEACECPA1ACE2NAALAD2 | |
| SCHEMBL11548564 | 1.00 | MME (0.61) | MMEACECPA1ACE2NAALAD2 | |
| SCHEMBL135366 | 1.00 | MME (0.61) | MMEACECPA1ACE2NAALAD2 | |
| SCHEMBL8761646 | 1.00 | MME (0.61) | MMEACECPA1ACE2NAALAD2 | |
| SCHEMBL8206518 | 0.98 | MME (0.60) | MMEACECPA1ACE2NAALAD2 | |
| Water SCHEMBL27822843 | 0.98 | MME (0.60) | MMEACECPA1ACE2NAALAD2 | |
| Hydrochloric Acid SCHEMBL9136406 | 0.98 | MME (0.60) | MMEACECPA1ACE2NAALAD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 222 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104628819-B | A kind of technique that coupling reaction generates Aspartame | 常茂生物化学工程股份有限公司 | 2019-05-21 | — | — | CN | claimed |
| CN-107076753-B | Specific biomarker composition for obese people and application thereof | 深圳华大基因科技有限公司 | 2019-01-18 | — | — | CN | claimed |
| WO-2017189528-A1 | CORROSION INHIBITOR COMPOSITIONS AND METHODS OF USING SAME | Ecolab USA, Inc. (US) | 2017-11-02 | — | — | WO | claimed |
| CN-107076753-A | Obese people specific biological marking composition and application thereof | 深圳华大基因科技有限公司 | 2017-08-18 | — | — | CN | claimed |
| CN-1615359-B | Method for producing L-amino acid using bacterium belonging to genus Escherichia | AJINOMOTO KK | 2010-04-28 | — | — | CN | claimed |
| EP-1261623-A4 | NEW RETINOL DERIVATIVES, THE METHOD OF PREPARATIONS AND THE USES THEREOF | CHEBIGEN INC (KR) | 2007-04-25 | — | — | EP | claimed |
| US-7030265-B2 | Retinol derivatives, the method of preparations and the uses thereof | CHEBIGEN, INC. (KR) | 2006-04-18 | — | — | US | claimed |
| US-20040023888-A1 | Retinol derivatives, the method of preparations and the uses thereof | CHEBIGEN INC. (KR) | 2004-02-05 | — | — | US | claimed |
| CN-1455780-A | novel retinol derivatives, preparation method and use thereof | CHEBIGEN INC (KR) | 2003-11-12 | — | — | CN | claimed |
| EP-1261623-A1 | NEW RETINOL DERIVATIVES, THE METHOD OF PREPARATIONS AND THE USES THEREOF | Chebigen Inc. (KR) | 2002-12-04 | — | — | EP | claimed |
| WO-1998008919-A2 | NOVEL WATER SOLUBLE METAL WORKING FLUIDS | SOLUTIA INC. (US) | 1998-03-05 | — | — | WO | claimed |
| EP-0661932-A4 | SPECIFIC EATABLE TASTE MODIFIERS. | BIORESEARCH INC (US) | 1996-06-05 | — | — | EP | claimed |
| EP-0661932-A1 | SPECIFIC EATABLE TASTE MODIFIERS | BIORESEARCH, INC. (US) | 1995-07-12 | — | — | EP | claimed |
| EP-0307496-B1 | PROCESS FOR THE PRODUCTION OF N-FORMYL-ASPARTYL-PHENYLALANINE OR ITS METHYL ESTER | AJINOMOTO CO., INC. (JP) | 1993-06-30 | — | — | EP | claimed |
| WO-1993010677-A1 | SPECIFIC EATABLE TASTE MODIFIERS | BIORESEARCH, INC. (US) | 1993-06-10 | — | — | WO | claimed |
| WO-1992000953-A1 | A ONE-POT PROCESS FOR THE PREPARATION OF ALPHA-L-ASPARTYL-L-PHENYLALANINE METHYL ESTER HYDROCHLORIDE | THE NUTRASWEET COMPANY (US) | 1992-01-23 | — | — | WO | claimed |
| EP-0307496-A1 | Process for the production of N-formyl-aspartyl-phenylalanine or its methyl ester | AJINOMOTO CO., INC. (JP) | 1989-03-22 | — | — | EP | claimed |
| EP-0214941-A2 | Method for the removal of the formyl group from an ester of an N-formyl peptide or N-formyl aminoacid | LARK S.p.A. (IT) | 1987-03-18 | — | — | EP | claimed |
| EP-0196866-A2 | Preparation process of alpha-L-aspartyl-L-phenylalanine methyl ester or hydrochloride thereof | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1986-10-08 | — | — | EP | claimed |
| EP-0048345-A1 | Process for the preparation of an alpha-L-aspartyl-L-phenylalanine-alkyl ester | CHIMICASA GMBH (CH) | 1982-03-31 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040023888-A1 | Retinol derivatives, the method of preparations and the uses thereof | RBP4, RBP1, ADH4 | MME 1400/4885ACE 2044/4885CPA1 1988/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.